Controls and calibrators are essential to the reliability of in vitro diagnostic testing, but they serve different purposes. Calibrators establish the relationship between instrument response and analyte concentration or activity, while controls help laboratories monitor whether the assay continues to perform as expected. Both require carefully selected matrices, stable analytes, reproducible manufacturing, and value-assignment strategies appropriate to the intended method.
As part of our IVD reagent and kit contract manufacturing service, Creative Enzymes Diagnostic develops customized controls and calibrators from initial specification and matrix design through analyte preparation, value assignment, homogeneity evaluation, stability studies, filling, and pilot production. Programs can support new assay kits, replacement of existing materials, expanded concentration ranges, multi-analyte products, or adaptation to a specific instrument platform.

Although controls and calibrators may contain the same analyte, they cannot automatically be used interchangeably. Their target concentrations, assigned values, acceptance ranges, matrices, packaging, and instructions must reflect their intended function within the assay. We define these requirements at project initiation to avoid design choices that compromise calibration accuracy or quality-control monitoring.
Calibrators
Control Materials
Development can begin with a required control or calibration profile, an existing product that needs replacement, or a diagnostic kit under development. The material format is selected according to the assay chemistry, analyte stability, laboratory workflow, intended shelf life, and manufacturing requirements.
Product Configurations
Storage and Presentation Formats
Development begins by translating the assay's operating needs into a material specification. We review the analyte, assay principle, instrument, calibration model, reportable range, clinical decision points, specimen matrix, user workflow, packaging, and desired shelf life. The result is a target profile that defines what the material must contain and how its performance will be assessed.
Control levels are selected to challenge the assay at meaningful positions rather than simply dividing the measuring interval into equal segments. Depending on the test, levels may represent the expected normal range, a medical decision point, a low-positive region, or a high-concentration condition. Calibrator levels are distributed to support the chosen mathematical model and must adequately define the assay response across the intended interval.
The development specification may define:
The matrix influences analyte recovery, reaction kinetics, binding, commutability, stability, microbial risk, and manufacturability. A matrix that stabilizes the analyte may still create bias relative to patient samples, while a highly native matrix may introduce supply, biosafety, or lot-variation challenges. We select and optimize the matrix according to the intended assay and the degree of clinical-sample similarity required.
Biological Matrices
Synthetic and Hybrid Matrices
Matrix preparation may include filtration, delipidation, dialysis, heat treatment, target depletion, clarification, microbial-control steps, or adjustment of endogenous constituents. Processing conditions are selected carefully because they can alter protein structure, analyte binding, turbidity, viscosity, and assay response. After treatment, the matrix is reassessed in the target method before analyte concentration is finalized.
The analyte source can affect immunoreactivity, catalytic activity, molecular form, post-translational modification, stability, and method response. We evaluate native, recombinant, purified, synthetic, inactivated, or otherwise characterized materials according to the assay principle. For multi-analyte products, each component must remain stable and measurable without adversely affecting the others.
Analyte Qualification
Level Preparation
Controls and calibrators must retain their assigned behavior throughout preparation, filling, storage, shipment, and use. Stabilization is optimized for the complete material rather than for the analyte alone. Buffer composition, protein content, preservatives, surfactants, antioxidants, chelators, sugars, polyols, and other excipients are screened for their effects on analyte recovery, matrix properties, assay response, and long-term consistency.
For lyophilized products, formulation work also addresses freezing stress, drying recovery, cake appearance, residual moisture, reconstitution time, and post-reconstitution stability. For liquid products, attention is given to adsorption, precipitation, microbial control, evaporation, and repeated opening. Container and closure materials are evaluated because surface interactions or moisture exchange can change the apparent analyte value over time.
Value assignment converts a prepared material into a usable calibrator or control. The strategy depends on the measurand, available reference systems, intended method, number of instruments and reagent lots, and whether the material is intended for calibration or quality control. Where suitable reference measurement procedures or certified reference materials are available, they can be incorporated into the traceability plan. When no higher-order reference exists, values may be assigned through a defined comparative or consensus procedure.
For control materials, the expected range must be broad enough to accommodate normal analytical variation but narrow enough to detect a meaningful shift. Ranges may be established for a specific assay, reagent lot, instrument family, or broader method group. We can also support reassignment after a formulation, matrix, instrument, or reagent change when the previous values are no longer directly applicable.
Commutability describes whether a reference material behaves like representative patient samples across different measurement procedures. It cannot be assumed from matrix type alone. Processing, analyte source, concentration adjustment, preservatives, and stabilization can all create method-dependent behavior. The required level of evaluation depends on the product's intended use and whether it will be used across one or multiple methods.
A comparative study can include patient samples spanning the relevant range together with the candidate control or calibrator. Relationships among methods are assessed to determine whether the material follows the same pattern as the clinical specimens. If a matrix-related bias is identified, we may adjust the matrix or analyte source, narrow the intended platform claim, or assign method-specific values rather than treating the material as universally interchangeable.
Homogeneity testing determines whether units from the same lot can be used interchangeably. Stability testing evaluates whether the assigned behavior is maintained over the proposed storage and use period. Both studies require a representative sampling plan, an analytical method with adequate precision, predefined acceptance criteria, and control of the testing sequence.
Homogeneity Studies
Stability Studies
Scale-up introduces risks that may not be visible during bench preparation. We define the order of addition, mixing time, temperature, equilibration, filtration, hold time, filling sequence, closure, and storage conditions needed to preserve material uniformity. Pilot batches are used to examine process yield, fill consistency, analyte recovery, and the effect of lyophilization or other processing steps.
Release testing is tailored to the product and may include appearance, reconstitution, pH, osmolality, protein concentration, analyte value, enzyme activity, qualitative status, vial-to-vial consistency, microbial or safety-related attributes, and performance in the intended assay. Batch records, material specifications, in-process controls, and acceptance criteria are prepared to support reproducible manufacture.

The final documentation package is aligned with the product type and development scope. Typical deliverables include:
| Item | Description |
|---|---|
| Product Target Profile | Definition of intended use, material type, analyte levels, matrix, assay platform, packaging, storage, stability, and performance requirements. |
| Matrix and Analyte Selection Report | Evaluation of candidate matrices and analyte sources, including background, recovery, functional response, processing requirements, and selection rationale. |
| Optimized Control or Calibrator Formulation | Recommended matrix composition, analyte concentration, stabilizers, preservatives, preparation sequence, and critical storage or handling conditions. |
| Prototype or Pilot Materials | Development-stage control or calibrator units prepared at the agreed levels and in the selected liquid, frozen, lyophilized, or kit-integrated format. |
| Value Assignment and Traceability Report | Assigned values or ranges, study design, analytical procedures, statistical summary, units, traceability statement, and identified limitations. |
| Homogeneity and Compatibility Data | Within-unit and between-unit results together with available method-comparison, matrix-effect, or commutability-related findings. |
| Stability Data and Study Plan | Available accelerated, real-time, transport, open-vial, freeze–thaw, or reconstituted stability results and recommendations for continued monitoring. |
| Manufacturing and QC Documentation | Draft production instructions, filling requirements, in-process controls, release tests, acceptance criteria, packaging recommendations, and scale-up considerations. |
Q1. What is the practical difference between a calibrator and a control?
Q2. Can the same matrix be used for both controls and calibrators?
Q3. Can you develop multi-analyte control materials?
Q4. How are target values assigned when no certified reference material is available?
Q5. Does a serum-based material automatically behave like a patient sample?
Q6. Can an existing control or calibrator be reformulated to improve shelf life?
Creative Enzymes Diagnostic combines assay-development experience, diagnostic raw material expertise, matrix engineering, analytical characterization, and scalable manufacturing support to create dependable controls and calibrators. Each program is designed around the material's intended function so that concentration levels, assigned values, stability, and production controls work together as a coherent product.
Contact our business development team today to discuss your custom control or calibrator development needs!